- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03919864
Connect Oncology Needs Evaluation Tool (CONNECT-LC)
July 11, 2023 updated by: Wake Forest University Health Sciences
Caregiver Oncology Needs Evaluation Tool (CONNECT): A Technology-Based Intervention to Connect Lung Cancer Caregivers With Supportive Care Resources
The purpose of this research study is to evaluate a technology-based intervention, Caregiver Oncology Needs Evaluation Tool (CONNECT), which may increase lung cancer caregivers' knowledge about the benefits of supportive care resources, identify their unmet needs, and connect them with supportive care resources.
The investigators will also determine their ability to recruit and keep patients and caregivers in the study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The long-term goal of this program of research is to improve supportive care delivery and lung cancer caregiver and patient well-being through a caregiver delivered intervention, Caregiver Oncology Needs Evaluation Tool (CONNECT).
The investigators propose to evaluate a novel technology-based intervention, CONNECT, informed by theory with input from an advisory panel including a lung cancer caregiver and stakeholders.
The purpose of CONNECT is to empower and educate caregivers about the benefits of supportive care resources and to systematically identify unmet needs and connect lung cancer caregivers with tailored supportive care resources.
CONNECT is designed to be low cost and to capture the various resources offered in different oncology environments to support future adaptation and dissemination for heterogeneous healthcare settings.
Study Type
Interventional
Enrollment (Actual)
78
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Comprehensive Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
For Caregivers:
- Caregivers must be providing some capacity of informal (unpaid) care for a patient meeting patient eligibility criteria. If a patient unexpectedly becomes deceased during the study period, caregivers will be allowed to continue participation in the assigned study arm and complete study assessments if they wish to.
- Caregivers must be > 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads.
For Patients:
- Patients must have a current diagnosis of limited stage small cell or stage 1-4 nonsmall cell lung cancer.
- Patients must be currently receiving or planning to receive treatment for their cancer at the time of enrollment. For patients receiving surgery, the eligibility timeframe will include 6 weeks following the date of surgery to account for the acute recovery period.
- Patients must be ambulatory and up more than 50% of waking hours, as measured by an ECOG Performance Status rating of level 0, 1, or 2.
- Patients must be > 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads.
- Patients must be receiving some capacity of informal care from a caregiver meeting the above criteria. If the caregiver unexpectedly becomes deceased during the study period, the patient will be un-enrolled from this study as we are evaluating a caregiver-only delivered intervention.
Exclusion Criteria:
For Caregivers:
• Caregivers cannot read/ communicate in English.
For Patients:
- Patients who are post-treatment survivors at the time of study enrollment. For patients receiving surgery only, this includes the period beyond acute recovery (i.e. ≥ 7 weeks post-surgery).
- Caregivers cannot read/ communicate in English.
Eligibility to participate in the study is conditional on participation of both the caregiver and patient.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: CONNECT Intervention Group
CONNECT includes a multi-component e-tool with the following: (1) a brief educational video that seeks to empower and educate caregivers about the importance of self-care and benefits of supportive care resource use; (2) an assessment of multidimensional supportive care needs (e.g., psychological, behavioral, social, financial, educational, spiritual); (3) a tailored resource list that includes local and national resources corresponding to caregivers needs (Table1); and (4) an optional automated referral to a caregiver navigator to facilitate connection to resources.
|
Participants will be included in a multi-component e-tool with brief educational videos, an assessment of multidimensional supportive care needs, a tailored resource list and an optional automated referral to a caregiver navigator.
Two weeks after baseline participants will receive re-education and an optional referral.
|
|
Other: CONTROL Group
Control arm participants will receive a generic (i.e., not tailored) printed list of hospital, community, and national supportive care resources.
Control participants will not receive the educational video, complete the E-tool Preference survey, or have an option for an automated referral to a caregiver navigator
|
Participants will receive a generic printed list of hospital, community, and national supportive care resources.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Eligible Participants
Time Frame: Approximately 3 months
|
The number of eligible participants who agreed to participate in this study
|
Approximately 3 months
|
|
Accrual
Time Frame: Approximately 3 months
|
Number of caregivers who agreed to participate divided by the number of months of recruitment.
|
Approximately 3 months
|
|
Retention of Participants
Time Frame: Approximately 3 months
|
Number of participants who completed the T2 assessment divided by the number who agreed to participate
|
Approximately 3 months
|
|
Participants Acceptability of the CONNECT Program Survey
Time Frame: Approximately 3 months
|
A 10-item survey developed for study to assess how much caregivers liked different aspects of CONNECT.
|
Approximately 3 months
|
|
Acceptability of CONNECT Program Interview
Time Frame: Approximately 3 months
|
A 20-minute qualitative interview to explore factors associated with acceptability.
During interviews, CONNECT elements will be reviewed and open-ended questions will be used to elicit feedback on functionality, strengths, and weaknesses of the e-tool.
Interview recordings will be transcribed verbatim.
|
Approximately 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Supportive Care Service Utilization Survey for Caregivers
Time Frame: Baseline to 3 months
|
Survey developed for the purpose of this study to query participants about utilization of supportive care services assessed as part of the CONNECT Preferences Survey.
Survey instructions will reflect current assessment (T0, T1, T2 - T0 since your loved one's diagnosis and T1 and T2 since using the online CONNECT program).
Caregivers will be asked to think about services or resources from any places they may have gone to for supportive care using the T0, T1, T2 timeframe.
Rating scales consists of (Yes, I used this, No, I did not need this, No, I wish this had been available to me and I do not know what this is or if is was available).
|
Baseline to 3 months
|
|
PROMIS Emotional Distress-Anxiety-Short Form 8a for Caregivers
Time Frame: Baseline to 3 months
|
An 8-item instrument that assesses fear, anxious misery, hyperarousal, and somatic symptoms related to arousal; widely used in oncology populations.
Response options range from NEVER to ALWAYS.
|
Baseline to 3 months
|
|
PROMIS Emotional Distress- Depression Short Form 8a for Caregivers
Time Frame: Baseline to 3 months
|
An 8-item instrument that assesses sadness, guilt, self-criticism, worthlessness, loneliness, interpersonal alienation, as well as loss of Interest, meaning, and purpose.
Response options range from NEVER to ALWAYS
|
Baseline to 3 months
|
|
Caregiver Reaction Assessment (Burden) for Caregivers
Time Frame: Baseline to 3 months
|
A 24-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health).
Rating scale is based on participants' responses that best describe how they currently feel (Strongly disagree to strongly agree).
|
Baseline to 3 months
|
|
Caregiver Quality of Life Index-Cancer (CqoL-Canc) for Caregivers
Time Frame: Baseline to 3 months
|
A 35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns).
Response options are based on how true each statement has been for the caregiver during the PAST WEEK.
Options (not at all, a little bit, somewhat, quite a bit or very much).
|
Baseline to 3 months
|
|
FAMCARE (Perceived care quality) Questionnaire for Caregivers
Time Frame: Baseline to 3 months
|
A 20-item instrument to assess family caregiver satisfaction with information giving, availability of care, physical patient care, and symptom control.
Rating scale options are very satisfied to very dissatisfied.
|
Baseline to 3 months
|
|
FAMCARE (Perceived care quality) Questionnaire for Participants
Time Frame: Baseline to 3 months
|
A 20-item instrument to assess participant satisfaction with information giving, availability of care, physical patient care, and symptom control.
Rating scale options are very satisfied to very dissatisfied.
|
Baseline to 3 months
|
|
SF-1247 (Mental and physical well-being) Survey for Participants
Time Frame: Baseline to 3 months
|
A 12-item instrument measuring physical and mental well-being of the participants (particularly in the past four weeks).
Participants will answer from a scale of 1 = excellent to 5 = poor.
|
Baseline to 3 months
|
|
Proportion of Unplanned Hospitalizations
Time Frame: Baseline to 3 months
|
Survey designed for the purpose of the study to capture patient self-reported unplanned healthcare utilization.
Total score will reflect number of unplanned visits to the emergency room, urgent care, or healthcare provider.
|
Baseline to 3 months
|
|
Interventionist Notes - E-Tool Preference Survey
Time Frame: Baseline to 3 months
|
A 17-item survey consisting of various resources that participants and their caregivers would like more information on and accessibility of these resources.
Response options are YES or NO with the option to select multiple options for obtaining access.
|
Baseline to 3 months
|
|
MD Anderson Symptom Inventory for Lung Cancer Questionnaire
Time Frame: Baseline to 3 months
|
A 16-item instrument to assess lung cancer specific and general symptoms and the impact on daily functioning.
Participants will rate the severity of their symptoms in the last 24 hours based on a scale of 0 = not present to 10 - as bad as you can imagine.
|
Baseline to 3 months
|
|
Caregiver Risk Scale
Time Frame: Baseline to 3 months
|
A 7-item measure to assess caregiver behaviors for managing self-care.
This scale consists of questions that can be answered YES or NO.
|
Baseline to 3 months
|
|
Caregiver Barriers Survey
Time Frame: Baseline to 3 months
|
A 16-item survey developed for the purpose of this study to assess caregiver barriers to accessing supportive care.
Response options: Always, very often, sometimes, rarely, never.
|
Baseline to 3 months
|
|
Snyder State Hope Scale for Participants
Time Frame: Baseline to 3 months.
|
6-item instrument to assess hope of participants.
Score on an 8-point Likert scale with anchor scores of 1 (definitely true) to 8 (definitely false).
Higher scores reflect greater state of hope.
|
Baseline to 3 months.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Supportive Care Service Utilization Survey for Caregivers
Time Frame: Baseline to 3 months
|
Survey developed for the purpose of this study to query participants about utilization of supportive care services assessed as part of the CONNECT Preferences Survey.
Survey instructions will reflect current assessment (T0, T1, T2 - T0 since your loved one's diagnosis and T1 and T2 since using the online CONNECT program).
Caregivers will be asked to think about services or resources from any places they may have gone to for supportive care using the T0, T1, T2 timeframe.
Rating scales consists of (Yes, I used this, No, I did not need this, No, I wish this had been available to me and I do not know what this is or if is was available).
|
Baseline to 3 months
|
|
PROMIS Emotional Distress-Anxiety-Short Form 8a for Caregivers
Time Frame: Baseline to 3 months
|
An 8-item instrument that assesses fear, anxious misery, hyperarousal, and somatic symptoms related to arousal; widely used in oncology populations.
Response options range from NEVER to ALWAYS.
|
Baseline to 3 months
|
|
PROMIS Emotional Distress- Depression Short Form 8a for Caregivers
Time Frame: Baseline to 3 months
|
An 8-item instrument that assesses sadness, guilt, self-criticism, worthlessness, loneliness, interpersonal alienation, as well as loss of Interest, meaning, and purpose.
Response options range from NEVER to ALWAYS
|
Baseline to 3 months
|
|
Caregiver Reaction Assessment (Burden) for Caregivers
Time Frame: Baseline to 3 months
|
A 24-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health).
Rating scale is based on participants' responses that best describe how they currently feel (Strongly disagree to strongly agree).
|
Baseline to 3 months
|
|
Caregiver Quality of Life Index-Cancer (CqoL-Canc) for Caregivers
Time Frame: Baseline to 3 months
|
A 35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns).
Response options are based on how true each statement has been for the caregiver during the PAST WEEK.
Options (not at all, a little bit, somewhat, quite a bit or very much).
|
Baseline to 3 months
|
|
FAMCARE (Perceived care quality) Questionnaire for Caregivers
Time Frame: Baseline to 3 months
|
A 20-item instrument to assess family caregiver satisfaction with information giving, availability of care, physical patient care, and symptom control.
Rating scale options are very satisfied to very dissatisfied.
|
Baseline to 3 months
|
|
FAMCARE (Perceived care quality) Questionnaire for Participants
Time Frame: Baseline to 3 months
|
A 20-item instrument to assess participant satisfaction with information giving, availability of care, physical patient care, and symptom control.
Rating scale options are very satisfied to very dissatisfied.
|
Baseline to 3 months
|
|
SF-1247 (Mental and physical well-being) Survey for Participants
Time Frame: Baseline to 3 months
|
A 12-item instrument measuring physical and mental well-being of the participants (particularly in the past four weeks).
Participants will answer from a scale of 1 = excellent to 5 = poor.
|
Baseline to 3 months
|
|
Proportion of Unplanned Hospitalizations
Time Frame: Baseline to 3 months
|
Survey designed for the purpose of the study to capture patient self-reported unplanned healthcare utilization.
Total score will reflect number of unplanned visits to the emergency room, urgent care, or healthcare provider.
|
Baseline to 3 months
|
|
Interventionist Notes - E-Tool Preference Survey
Time Frame: Baseline to 3 months
|
A 17-item survey consisting of various resources that participants and their caregivers would like more information on and accessibility of these resources.
Response options are YES or NO with the option to select multiple options for obtaining access.
|
Baseline to 3 months
|
|
MD Anderson Symptom Inventory for Lung Cancer Questionnaire
Time Frame: Baseline to 3 months
|
A 16-item instrument to assess lung cancer specific and general symptoms and the impact on daily functioning.
Participants will rate the severity of their symptoms in the last 24 hours based on a scale of 0 = not present to 10 - as bad as you can imagine.
|
Baseline to 3 months
|
|
Caregiver Risk Scale
Time Frame: Baseline to 3 months
|
A 7-item measure to assess caregiver behaviors for managing self-care.
This scale consists of questions that can be answered YES or NO.
|
Baseline to 3 months
|
|
Caregiver Barriers Survey
Time Frame: Baseline to 3 months
|
A 16-item survey developed for the purpose of this study to assess caregiver barriers to accessing supportive care.
Response options: Always, very often, sometimes, rarely, never.
|
Baseline to 3 months
|
|
Snyder State Hope Scale for Participants
Time Frame: Baseline to 3 months.
|
6-item instrument to assess hope of participants.
Score on an 8-point Likert scale with anchor scores of 1 (definitely true) to 8 (definitely false).
Higher scores reflect greater state of hope.
|
Baseline to 3 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Chandylen Nightingale, Ph.D, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 18, 2019
Primary Completion (Actual)
July 24, 2020
Study Completion (Actual)
July 24, 2020
Study Registration Dates
First Submitted
April 12, 2019
First Submitted That Met QC Criteria
April 15, 2019
First Posted (Actual)
April 18, 2019
Study Record Updates
Last Update Posted (Actual)
July 13, 2023
Last Update Submitted That Met QC Criteria
July 11, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00054952
- WFBCCC 04319 (Other Identifier: Wake Forest Baptist Comprehensive Cancer Center)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Cancer
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; MedWaves, IncRecruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCaregiver | Stage III Lung Cancer AJCC v7 | Stage I Lung Cancer AJCC v7 | Stage II Lung Cancer AJCC v7 | Stage IB Lung Cancer AJCC v7 | Stage IA Lung Cancer AJCC v7 | Stage IIA Lung Cancer AJCC v7 | Stage IIB Lung Cancer AJCC v7 | Stage IIIA Lung Cancer AJCC v7 | Stage IIIB Lung Cancer AJCC v7United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedStage IV Lung Cancer | Stage III Lung Cancer | Stage I Lung Cancer | Stage II Lung CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Head and Neck Carcinoma | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
Clinical Trials on CONNECT Intervention
-
University of South CarolinaNational Institute of Nursing Research (NINR)RecruitingConnect Through PLAY: A Staff-based Physical Activity Intervention for Middle School Youth (Connect)Physical Activity | Obesity PreventionUnited States
-
University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPhysical Activity | Obesity Prevention
-
US Department of Veterans AffairsDuke UniversityCompletedAccidental FallsUnited States
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)CompletedHIV | Sexually Transmitted InfectionsUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH)Completed
-
Minnesota Department of HealthCompleted
-
New York UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD); Hofstra...Not yet recruitingChildhood Apraxia of Speech
-
George Washington UniversityBill and Melinda Gates Foundation; Save the Children; Save the Children International...CompletedContraceptive UsageBangladesh
-
George Washington UniversityBill and Melinda Gates Foundation; Save the Children; Save the Children International...CompletedContraceptive UsageTanzania
-
RANDNational Institute of Mental Health (NIMH); University of Stellenbosch; Western...Completed